NASDAQ:ENOB Enochian Biosciences (ENOB) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.40▼$0.7952-Week Range N/AVolume88,300 shsAverage Volume137,347 shsMarket Capitalization$40.80 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Enochian Biosciences alerts: Email Address Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. About Enochian Biosciences Stock (NASDAQ:ENOB)Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and cancer. The company's product pipeline includes ENOB-HV-01 for autologous HIV curative treatment; ENOB-HV-12, a therapeutic HIV vaccine; and ENOB-HB-01, a gene therapy curative treatment for HBV. It develops ENOB-DC-11, an allogeneic dendritic cell therapeutic vaccine for solid tumors; ENOB-DC-12-XX, allogeneic dendritic cell therapeutic vaccine for other solid tumors; and ENOB-HV-21 for treating HIV with allogeneic natural killer (NK) and gamma delta T-cells. Enochian Biosciences, Inc. has strategic partnerships with the University of California, Fred Hutchinson Cancer Research Center, and Caring Cross. The company was incorporated in 2017 and is headquartered in Los Angeles, California.Read More Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. ENOB Stock News HeadlinesMarch 2, 2024 | msn.comCITY WHISPERS: Dr No's firm in rebrand after Hindenburg disasterFebruary 13, 2024 | msn.comRenovaro Biosciences Faces Turmoil After Hindenburg Report Accusing Questionable Merger And Governance, Stock CrashesSeptember 7, 2024 | Weiss Ratings (Ad)“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.November 23, 2023 | investing.comEastern & Oriental Bhd (ENOB)October 24, 2023 | benzinga.comAkoya Biosciences Stock (NASDAQ:AKYA), Analyst Ratings, Price Targets, PredictionsOctober 3, 2023 | theglobeandmail.comRenovaro BioSciences (NASDAQ: RENB) CEO Releases Shareholder LetterSeptember 30, 2023 | theglobeandmail.comRenovaro BioSciences (NASDAQ: RENB) Enters Definitive Agreement to Combine with Leading AI Tech GEDi CubeSeptember 11, 2023 | barrons.comRenovaro Biosciences Inc.September 7, 2024 | Weiss Ratings (Ad)“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.September 3, 2023 | investing.comRenovaro Biosciences Inc (RENB)August 21, 2023 | finance.yahoo.comRenovaro BioSciences Congratulates GEDi Cube on Appointment of its Chief Medical OfficerAugust 10, 2023 | finance.yahoo.comRenovaro BioSciences, GEDi Cube Announce LOI to Merge, Focus on Fight Against CancerAugust 9, 2023 | finance.yahoo.comAI Company GEDi Cube and Renovaro Biosciences Announce a Binding, Exclusive Letter of Intent to Merge, Accelerating Fight Against CancerJuly 25, 2023 | finance.yahoo.com3 Doomed Biotech Stocks Destined for DisasterJune 23, 2023 | finanznachrichten.deEnochian BioSciences, Inc.: Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder MeetingJune 23, 2023 | finance.yahoo.comEnochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder MeetingJune 8, 2023 | finanznachrichten.deEnochian BioSciences, Inc.: Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA ReviewJune 8, 2023 | finance.yahoo.comEnochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA ReviewSee More Headlines Receive ENOB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Enochian Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today9/07/2024Fiscal Year End6/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:ENOB CUSIPN/A CIK1527728 Webwww.enochianbio.com Phone(305) 918-1980FaxN/AEmployees22Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-113,430,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-154.69% Return on Assets-130.66% Debt Debt-to-Equity RatioN/A Current Ratio0.33 Quick Ratio0.33 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.37 per share Price / BookN/AMiscellaneous Outstanding Shares58,280,000Free Float45,625,000Market Cap$40.80 million OptionableNot Optionable Beta1.09 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesDr. Mark R. Dybul M.D. (Age 60)CEO, Director & Member of HBV Scientific Advisory Board Comp: $950kMs. Luisa Puche (Age 59)CFO & Corp. Sec. Comp: $403.75kDr. Serhat GümrükcüCo-Founder & InventorDr. Francois Binette M.Sc. (Age 59)Ph.D., Chief Operating Officer Mr. Greg Duczynski Ph.D.Sr. VP for Clinical OperationsKey CompetitorsLumos PharmaNASDAQ:LUMOAclaris TherapeuticsNASDAQ:ACRSGeneration BioNASDAQ:GBIOProQR TherapeuticsNASDAQ:PRQRGalectin TherapeuticsNASDAQ:GALTView All Competitors ENOB Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Enochian Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Enochian Biosciences investors own include AcelRx Pharmaceuticals (ACRX), Aptinyx (APTX), Axcella Health (AXLA), Aytu BioPharma (AYTU), Calithera Biosciences (CALA), Cidara Therapeutics (CDTX) and Catalyst Pharmaceuticals (CPRX). This page (NASDAQ:ENOB) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enochian Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enochian Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.